<DOC>
	<DOCNO>NCT01515397</DOCNO>
	<brief_summary>The aim volume replacement compensate reduction intravascular volume e.g . surgery counteract hypovolemia order maintain hemodynamics vital function . To achieve , different plasma substitute available : Albumin , dextran , hydroxyethylstarches gelatine . The aim study demonstrate acid-base alteration elective abdominal surgery reduce use new gelatine solution .</brief_summary>
	<brief_title>Comparison Two Gelatine Solutions</brief_title>
	<detailed_description />
	<mesh_term>Hypovolemia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Polygeline</mesh_term>
	<criteria>Inclusion : Male female patient &gt; = 18 year age &lt; = 90 year age . Women child bear potential must test negative standard pregnancy test . Patients schedule undergo elective abdominal surgery ( e.g . Rectal resection , liver resection , open bowl resection , duodenopancreatectomy reconstitution ) . Scheduled intraoperative volume requirement least 15 ml / kg body weight ( BROCA ) gelatine solution Provision voluntary consent participate study , follow full explanation nature purpose study , sign informed consent form approve Institutional Ethics Committee ( IEC ) prior evaluation . Exclusion : Patients ASAclass &gt; III Known hypersensitivity gelatine constituent solution Patients treat colloid solution / blood product 24 hour prior surgery Patients hemodialysis Patients suffer decompensated renal function ( i.e . serum creatinine &gt; 3.0 mg/dl ) Patients suffer Hypervolemia Hyperhydration Severe blood coagulation disorder Hypernatremia ( serum ( Na+ ) &gt; 150 mmol/L ) Hyperchloremia ( serum ( Cl ) &gt; 110 mmol/L ) Estimated perioperative need blood product 3,5 ml / kg body weight ( BROCA ) Lactation period Simultaneous participation another clinical trial Emergencies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>